Cargando…

Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial

BACKGROUND/AIMS: S-isomer (S) pantoprazole is more bioavailable and less dependent on cytochrome 2C19 than is racemic pantoprazole. We aim to evaluate the efficacy and safety of 10 mg S-pantoprazole for treatment of non-erosive reflux disease (NERD). METHODS: In this phase 3, double-blind, randomize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yu Kyung, Choi, Myung-Gyu, Park, Hyojin, Kim, Ji Won, Lee, Dong Ho, Ko, Kwang Hyun, Kim, Sang Gyun, Jung, Hwoon-Yong, Hong, Su Jin, Lee, Yong Chan, Lee, Si Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Neurogastroenterology and Motility 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026380/ https://www.ncbi.nlm.nih.gov/pubmed/33795542 http://dx.doi.org/10.5056/jnm19053

Ejemplares similares

Randomised clinical trial: comparison of tegoprazan and placebo in non‐erosive reflux disease
por: Kim, Seung Han, et al.
Publicado: (2021)

Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016)

Long-term management of gastroesophageal reflux disease with pantoprazole
por: Scholten, Theo
Publicado: (2007)

In Which Situation is Endoscopic Radiofrequency Anti-Reflux Therapy (Stretta) Effective for Controlling Gastroesophageal Reflux Symptoms?
por: Jung, Hwoon-Yong
Publicado: (2021)

An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease
por: Mathews, Sony, et al.
Publicado: (2010)

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022)

Significance of Non-erosive Minimal Esophageal Lesions in Gastro-esophageal Reflux Disorder
por: Hong, Sung-Pyo, et al.
Publicado: (2004)

Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study
por: Kim, Eun Jin, et al.
Publicado: (2019)

Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria
por: Noh, Young Wook, et al.
Publicado: (2010)

Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study
por: Kim, Young Min, et al.
Publicado: (2022)

Comparison of Direct Medical Care Costs Between Erosive Reflux Disease and Non-erosive Reflux Disease in Korean Tertiary Medical Center
por: Seo, Pyoung Ju, et al.
Publicado: (2010)

Central Obesity as a Risk Factor for Non-Erosive Reflux Disease
por: Kim, Ki Ju, et al.
Publicado: (2017)

Association Between Non-erosive Reflux Disease and High Risk of Obstructive Sleep Apnea in Korean Population
por: You, Chan Ran, et al.
Publicado: (2014)

Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients
por: Goh, Khean Lee, et al.
Publicado: (2014)

The Impact of Erosive Reflux Esophagitis on the Decline of Lung Function in the General Population
por: Kang, Hye-Rin, et al.
Publicado: (2021)

Effect of Monotherapy and Combination Therapy of Pantoprazole and Aprepitant in Gastric Esophageal Reflux Disease in Albino Rats
por: Shukla, Kamleshwar, et al.
Publicado: (2014)

Gastroesophageal Reflux Disease Associated With Anxiety: Efficacy and Safety of Fixed Dose Combination of Amitriptyline and Pantoprazole
por: Faruqui, Arif A.
Publicado: (2017)

Evaluating ranitidine, pantoprazole and placebo on gastric pH in elective surgery
por: Bhattacharyya, Tapas, et al.
Publicado: (2011)

Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients
por: Deppe, Herbert, et al.
Publicado: (2015)

Differences in Clinical Characteristics between Patients with Non-Erosive Reflux Disease and Erosive Esophagitis in Korea
por: Ha, Na Rae, et al.
Publicado: (2010)

A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
por: Park, Su Hyun, et al.
Publicado: (2023)

Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea
por: Choi, Yoon Jin, et al.
Publicado: (2017)

Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study
por: Park, Chan Hyuk, et al.
Publicado: (2020)

Environmentally Benign and Facile Process for the Synthesis of Pantoprazole Sodium Sesquihydrate: Phase Transformation of Pantoprazole Sodium Heterosolvate to Pantoprazole Sodium Sesquihydrate
por: Awasthi, Arun Kumar, et al.
Publicado: (2017)

Comparison of macroscopic abnormalities in patients receiving routine pantoprazole when compared to placebo
por: Summers, MJ, et al.
Publicado: (2015)

Early experiences of minimally invasive surgery to treat gastroesophageal reflux disease
por: Lee, Sae Byul, et al.
Publicado: (2013)

Gastroesophageal Reflux Disease and Tooth Erosion
por: Ranjitkar, Sarbin, et al.
Publicado: (2012)

Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015)

Role of non-acid reflux in patients with non-erosive reflux disease
por: Karamanolis, Georgios P., et al.
Publicado: (2013)

Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease – PAN-STAR
por: Dabrowski, Andrzej, et al.
Publicado: (2018)

Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report
por: Smith, Joe S., et al.
Publicado: (2021)

Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia
por: Maity, Somnath, et al.
Publicado: (2014)

Gender-specific Effect of Micronutrient on Non-erosive Reflux Disease and Erosive Esophagitis
por: Nam, Su Youn, et al.
Publicado: (2019)

Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group
por: López-Alvarenga, Juan Carlos, et al.
Publicado: (2014)

Association of Gastroesophageal Reflux Disease With Dental Erosion
por: Chakraborty, Ananya, et al.
Publicado: (2022)

Confocal Laser Endomicroscopic Findings of Refractory Erosive Reflux Disease versus Non-Erosive Reflux Disease with Anti-Reflux Mucosectomy: An in vivo and ex vivo Study
por: Jeong, Eunju, et al.
Publicado: (2021)

Pantoprazole-related Symptomatic Hyponatremia
por: Ferreira, Filipa, et al.
Publicado: (2016)

Comparison of Characteristics According to Reflux Type in Patients With Laryngopharyngeal Reflux
por: Lee, Jun Seok, et al.
Publicado: (2018)

Bioequivalence Study of Pantoprazole Sodium-HPBCD and Conventional Pantoprazole Sodium Enteric-Coated Tablet Formulations
por: Kamdi, Sandesh P., et al.
Publicado: (2013)

Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
por: Cho, Young Gyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k1f4ehv8ltagmd8d0i7i9hm5o2